Reports of counterfeit cannabis have reinforced the critical need to protect bonafide products and packaging, says the International Hologram Manufacturers Association (IHMA).
Sales of synthetic cannabinoids being mis-sold as cannabis are on the rise in the UK, presenting a significant health risk to the general public, reports a harm reduction project* that analyses samples of drugs provided by the public and other participating organisations.
With the increased legalisation of the drug around the world, including in many US states, the IHMA believes it is critically important regulated cannabis products used for pain relief, relaxation and sleeping disorders, are protected fully and secure from the threat of criminal counterfeiters.
- ANDY BRUCE
- Industry News
- Posted On